Tabula Rasa Healthcare

Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services. Its brands include CareKinesis, Capstone Risk Adjustment Services, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides Medication Therapy Management, or MTM, software and services for Medicare, Medicaid, and commercial health plans, and also provides a cloud-based patient engagement software and services. It offers cloud-based software and clinical pharmacist services through its brands, including MedWise, SinfoníaRx, RxCompanion, PrescribeWellness, and DoseMeRx. The company was founded by Calvin H. Knowlton, Orsula V. Knowlton, and Michael Greenhalgh in April 2009 and is headquartered in Moorestown, NJ.

Earnings data Q4 2019

Earnings data Q1 2020

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q2 2024

Tabula Rasa HealthCare reports robust Q4 growth and strategic investments

Tabula Rasa HealthCare's Q4 2022 performance reflects strong revenue growth and strategic initiatives to enhance profitability.
While facing challenges in technology-enabled solutions revenue and execution risks, the company is well-positioned for growth.
Opportunities in automation investments and MedWise platform expansion offer avenues for sustained revenue growth and market impact.

Tabula Rasa HealthCare (TRHC) excels in Q1 2023 earnings, eyes expansion

Tabula Rasa HealthCare (TRHC) delivered strong financial performance in Q1 2023, driven by revenue growth, profitability focus, and strategic initiatives.
The company faces challenges from drug price inflation and contract turnover impact but is well-positioned for future expansion and market penetration.
TRHC's emphasis on customer-centric strategies, PACE program growth, and efficient resource management sets the stage for continued success and revenue growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tabula Rasa provides state-of-the-art medication management through a combination of technology, science and services that reduces costs, improves the quality of care and decreases the risks associated with ineffective medication plans.

MOORESTOWN, N.J., March 18, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the safe use of medications, announced that on March 17, TRHC Chair and CEO, Calvin H.

Tabula Rasa HealthCare Supports Legislation to Establish Medication Risk Reduction Program for NJ Medicaid.

MOORESTOWN, N.J., March 10, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ: TRHC), a healthcare technology company advancing the safe use of medications, announces an agreement with eight state pharmacy associations: Missouri, Oregon, Kansas, Kentucky, Maryland, Indiana, Virginia, and North Dakota.

Tabula Rasa HealthCare Signs Agreement with Multiple State Pharmacy Associations to Bring Medication Risk Mitigation Technology to Members

MOORESTOWN, N.J., March 8, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ: TRHC), a healthcare technology company advancing safe use of medication, announced an all-time high for PACE census enrollment and one of the best net enrollment months in company history in...

Tabula Rasa HealthCare Reports Marked Improvement in PACE Census Metrics and Continued Cross-Selling Success during March 2021

Tabula Rasa HealthCare's (TRHC) CEO Calvin Knowlton on Q4 2020 Results - Earnings Call Transcript

MOORESTOWN, N.J., Feb. 23, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("TRHC") (Nasdaq: TRHC), a healthcare technology company advancing the safe use of medications, today reported financial results for the fourth quarter and full year ended December 31, 2020. "We finished a...

Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2020 Results

SYOSSET, N.Y., Feb. 16, 2021 /PRNewswire/ -- Micro Merchant Systems announces that its PrimeRx™ pharmacy technology software offers direct integration with the automated immunization reporting solution offered by Tabula Rasa HealthCare's (TRHC) Script Management Partners (SMP). With this...

PrimeRx™ and Tabula Rasa HealthCare Now Offer Integration Technology for Automated COVID-19 Vaccine Reporting

MOORESTOWN, N.J., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), today announced CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; Co-Founder, President, Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD; Chief Sales Officer, Kevin Boesen; and Chief Financial Officer, Brian W. Adams, will participate in the 39th Annual J.P. Morgan Healthcare Conference to be held virtually January 11-14, 2021.

Tabula Rasa HealthCare to Participate in Upcoming J.P. Morgan Investor Conference

MOORESTOWN, N.J., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces today it has entered into a partnership with Physiomics plc (AIM: PYC), the oncology consultancy using mathematical models to support the development of cancer treatment regimens and personalized medicine solutions. Through this initiative, Physiomics' personalized docetaxel model will be integrated into TRHC's market-leading precision dosing solution, DoseMeRx®. Both parties expect positive feedback from this initial trial with the next step being a commercial agreement.

TRHC's DoseMeRx® Partners with Physiomics to Provide Precision Dosing for Oncology Medications

Association members will have the opportunity to become Certified MedWise Advisors™ creating a State-Wide Network to support Value-Based Payer Agreements Association members will have the opportunity to become Certified MedWise Advisors™ creating a State-Wide Network to support Value-Based Payer Agreements

Tabula Rasa HealthCare Signs Agreement with Missouri Pharmacy Association to Provide Medication Safety Technology Education to Members

MOORESTOWN, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced a partnership between TRHC's Capstone Performance Systems service line and the American Academy of Home Care Medicine (AAHCM). As part of the partnership agreement, AAHCM will offer the newest program product from Capstone, Clinical Documentation Excellence (CDE) Online Education, to AAHCM members at a discounted rate, and Capstone will participate in AAHCM's Industry Relations Council (IRC).

American Academy of Home Care Medicine Partners with Tabula Rasa HealthCare to Offer Online Clinical Documentation Education for Members

MOORESTOWN, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc® (TRHC) ( NASDAQ:TRHC ), a healthcare technology company advancing the field of medication safety, today announced it is partnering with Heritage Health Solutions, Inc. (Heritage) to improve patient care and reduce costs for self-insured employers.

Tabula Rasa HealthCare Partners with Heritage Health Solutions to Expand Enhanced Medication Therapy Management Services to Self-insured Employers

MOORESTOWN, N.J., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (Nasdaq: TRHC), a healthcare technology company advancing the field of medication safety, announces today an agreement with the American College of Apothecaries (ACA). ACA, a national pharmacy organization dedicated to the advancement of professional practice in independent community pharmacy through entrepreneurship, will develop programing to educate ACA members on TRHC's medication safety software,  MedWise™ and promote the opportunity to become Certified MedWise Advisors ™.

TRHC Forms a Strategic Alliance with the American College of Apothecaries (ACA) to Market TRHC Solutions to Members

The Contract Spans Neil Medical Group's Network of Long-Term Care & Assisted Living Facilities Across the Southeastern United States The Contract Spans Neil Medical Group's Network of Long-Term Care & Assisted Living Facilities Across the Southeastern United States

Neil Medical Group Selects TRHC's DoseMeRx to Provide Precision Dosing Services For Long-term Care Facilities

Computer Programs and Systems

CPSI vs. TRHC: Which Stock Is the Better Value Option?

Tabula Rasa HealthCare, Inc. (TRHC) CEO Calvin Knowlton on Q3 2020 Results - Earnings Call Transcript

MOORESTOWN, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its third quarter 2020 operating results on Wednesday, November 4 , 2020 at 8 :30 a.m. EDT. The conference call will be hosted by TRHC CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; TRHC Co-Founder, President, Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD, MBA; and TRHC Chief Financial Officer, Brian W. Adams. The Company's financial results for the third quarter ended September 30, 2020, will be released after the close of the market on Tuesday, November 3 , 2020.

Tabula Rasa HealthCare Third Quarter 2020 Earnings Conference Call Announcement

MOORESTOWN, N.J. and WASHINGTON, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare , Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, in collaboration with the American Pharmacists Association (APhA), today launched the campaign, “Medication Safety Starts with a Pharmacist,” aimed at educating consumers on the importance of medication safety, the risks of adverse drug events (ADEs), and the essential role of the pharmacist on the patient care team.

Tabula Rasa HealthCare and the American Pharmacists Association Launch Medication Safety Campaign

MOORESTOWN, N.J., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced the acquisition of Personica, LLC and its subsidiaries PersonifilRx, Pharmastar and PersonifilRx New England (collectively, “Personica”), a provider of pharmacy services, including 340B and Medicare Part D administration solutions to Programs of All-inclusive Care for the Elderly (“PACE”).

Tabula Rasa HealthCare Expands CareVention HealthCare Offerings with the Addition of PersonifilRx and Pharmastar

MOORESTOWN, N.J., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced a partnership with Direct Scripts, a pharmacy solutions administrator focused on benefits management for self-insured employers.

Tabula Rasa HealthCare Announces Strategic Partnership with Direct Scripts to Provide Medication Therapy Management using MedWise™ to Self-insured Employer Markets

NextGen Healthcare Inc

NXGN vs. TRHC: Which Stock Is the Better Value Option?

NXGN or TRHC: Which Is the Better Value Stock Right Now?

MOORESTOWN, N.J., Sept.  17, 2020  (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc®  (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced that on Monday, September 14, TRHC Chairman and CEO, Calvin H. Knowlton, PhD appeared before the New Jersey Senate Health, Human Services and Senior Citizens Committee in support of a proposed amendment to Senate Bill No. 887, the Medicaid Prescription Drug Quality, Cost and Transparency Act. The proposed amendment would establish a medication risk prevention program within New Jersey Medicaid. 

Tabula Rasa HealthCare Supports Legislation Establishing Medication Risk Prevention Program for NJ Medicaid

Medplus will utilize MedWise to drive customized care and improved outcomes for patients. Medplus will utilize MedWise to drive customized care and improved outcomes for patients.

Tabula Rasa HealthCare and Medplus Solutions form Partnership to Bring MedWise™ Medication Safety Solutions to Puerto Rico

MOORESTOWN, N.J., Sept.  09, 2020  (GLOBE NEWSWIRE) --   Tabula Rasa HealthCare® Corporation (NASDAQ: TRHC) , a healthcare technology company advancing the field of medication safety, announced today three new accomplished technology leaders with decades of healthcare experience have joined its executive ranks since the start of 2020.

News for Tabula Rasa Healthcare Stock (TRHC)